Bayer Shifting Further To Emerging Markets Including China
This article was originally published in PharmAsia News
Executive Summary
Already a big player in the world's largest pharmemerging market, China, Bayer is plunging deeper and reallocating more resources in capital investment and manpower to emerging markets